American Association of Individual Investors4d
Which Is a Better Investment, Recursion Pharmaceuticals, Inc. or Zai Lab Limited Stock?
Learn more about whether Recursion Pharmaceuticals, Inc. or Zai Lab Limited is a better investment based on AAII's A+ ...
Business Insider8d
Zai Lab price target raised to $51 from $44 at JPMorgan
JPMorgan raised the firm’s price target on Zai Lab (ZLAB) to $51 from $44 and keeps an Overweight rating on the shares. The firm updated models in the small-cap biotechnology space. Published ...
Yahoo Finance9d
Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer
SHANGHAI & CAMBRIDGE, Mass., March 12, 2025--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has accepted ...